Jesse S. Voss

^Non-V600<i>BRAF</i> Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer

Jeremy Jones, Lindsay A. Renfro, Humaid O. Al‐Shamsi et al. · Journal of Clinical Oncology · 2017 · 352 citations · Full text

Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma

Benjamin R. Kipp, Jesse S. Voss, Sarah E. Kerr et al. · Human Pathology · 2012 · 238 citations

Tumor Biology, Isocitrate Dehydrogenase 1, Biliary Cancer +6

Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms

Robertson Mackenzie, Stefan Kommoss, Boris Winterhoff et al. · BMC Cancer · 2015 · 145 citations · Full text

An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples

Emily G. Barr Fritcher, Jesse S. Voss, Shannon M. Brankley et al. · Gastroenterology · 2015 · 138 citations

Pancreatic Cancer, Cancer Detection, Medicine +11

Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions

Jesse S. Voss, Leonard M. Holtegaard, Sarah E. Kerr et al. · Human Pathology · 2013 · 137 citations

Medicine, Hepatobiliary Tumor, Biliary Cancer +9